Add like
Add dislike
Add to saved papers

TREATMENT OF CHIARI III MALFORMATION IN INFANT WITH 4K 3D ORBEYE EXOSCOPE.

World Neurosurgery 2023 January 12
Chiari III malformation (CM-III) is the rarest anomaly among CMs1 . Treatment of choice is surgical repair2 , although poor outcome and postoperative mortality has been reported3 . Surgical timing is still debated4,5 . We present the case of a male infant with a prenatal diagnosis of encephalocele. Presentation was characterized by hemodynamic instability, horizontal nystagmus, and left shoulder dystocia due to caesarean section, with a 64x49x76 mm soft, fluctuant, and translucent suboccipital-cervical sac. MR revealed a median occipital bone defect with the meningoencephalic sac communicating with the vermian cistern and the fourth ventricle; moderate hydrocephalus, reduction of the posterior cranial fossa volume, hypoplasia of cerebellar hemispheric, vermian structures and corpus callosum hypoplasia. The patient underwent surgery on day-4 with the use of 4K 3D ORBEYE™ exoscope. Surgery consisted in disengagement of nervous structures and repair of the neurocutaneous defect, followed on day-12 by VP shunt with programmable valve. The procedures were well tolerated. At 14-months follow-up visit he was in range with Growth charts (weight, height and cranic circumference) and gained the physiological stages of growth, no motor impairment, still present convergent strabismus, mild left C5-C6 radiculopathy, secondary to shoulder dystocia. This is the first case reported in the literature of CM-III treated with the 4K 3D exoscope. Advantages of exoscope were ergonomic positions for operative staff, possibility for the team to assist in 4K 3D view, especially in cases with a narrow operative field, with a clear and detailed vision, although learning curve is required6 becoming a valid alternative in paediatric neurosurgery.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app